Correlation of the salival pH and volume with laryngeal-pharyngeal symptoms;Correlação do pH e volume salivares com sintomas laringofaríngeos

Revista Brasileira de Otorrinolaringologia

Volumn 70, Issue 1, 2004, Pages 24-28

  Olival Costa, Henrique ^a,b,c   Eckley, Cláudia Alessandra ^b  

^a Cirurgiao de Cabeca e Pescoco   (Brazil)

^b Santa Casa de Sao Paulo   (Brazil)

^c NONE   (Brazil)

Author keywords

Diagnosis; Laryngitis; pH; Saliva; Volume

Indexed keywords

ADULT; AGED; ARTICLE; CASEUM; DYSPHAGIA; DYSPNEA; FEMALE; GINGIVA DISEASE; GLOBUS PHARYNGEUS; GLOSSODYNIA; HALITOSIS; HUMAN; INFLAMMATION; LARYNGOPHARYNGEAL REFLUX; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; MUCOSA; ODYNOPHAGIA; PH MEASUREMENT; RECURRENT DISEASE; SALIVA; SYMPTOMATOLOGY; SYNDROME; THROAT DISEASE; TONSILLITIS; TOOTH DISEASE; XEROSTOMIA;

EID: 12344262895     PISSN: 00347299     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0034-72992004000100004     Document Type: Article

References (26)

1. Gavazzoni FB, De Ataíde AL, Herrero Junior F, Macedo Filho ED. Esofagite por refluxo e laringite por refluxo: estágios clínicos diferentes da mesma doença? Rev Bras ORL 2000; 68(1): 86-90.
2. Adhami T, Goldblum J, Richter J, Vaezi M. Role of gastric and duodenal ingredients in laryngeal tissue injury: an experimental study in dogs. Abstracts of the Digestive Disease Week 2002; 429: A-87.
3. Da Wes C. Circadian rythms in human salivary flow rate and composition. J Physiol 1972; 220:529-45.
4. Korsten MA, Rosman AS, Fishbein S, Shlein RD, Goldberg HE, Biener A. Chronic xerostomia increases esophageal acid exposure and in associated with esophageal injury. Am J Med 1991; 90:701-6.
5. Maccini DM & Veit BC. Salivary Epidermal Growth factor in Patients with and Without Acid Peptic Disease. Am J Gastroenterol 1990; 85(9): 1102-4.
6. Benamouzig R, Ferriere F, Guettier C, Amouroux J, Coste T, Rautureau J. Role of salivary and seric epidermal growth factor in pathogenisis of reflux esophagitis in chronic alcoholics and nondrinkers. Dig Dis & Sci 1996; 41(8): 1595-9.
7. Moazzez R, Anggiansah A, Bartlett D, Owen W. Tooth wear saliva and symptoms of GERD: is there a relationship? Abstracts of the Digestive Disease Week 2002; WI164: A-816.
8. Christensen ME, Therkildsen MH, Poulsen SS, Bretlau P. Transforming growth factor alpha and epidermal growth factor in laryngeal carcinomas demonstrated by immunohistochemistry. Acta Oto-Laryngol 1993; 113(4): 563-7.
9. Namiot Z, Rourk RM, Piascik R, Hetzel DP, Sarosiek J, Mccallum RW. Interrelationship between Esophageal Challenge with Mechanical and Chemical Stimuli and Salivary Protective Mechanisms. Am J Gastroenterol 1994; 89(4): 581-7.
10. Dagogo-Jack S. Epidermal growth factor EGF in human saliva: effect of age sex race pregnancy and sialagogue. Scand J Gastroenterol 1986; 21 (Suppl 124): 47-54.
11. Nandurkar S, Cameron A, Fett S, Zinsmeister A, Locke III GR. Environmental causes of reflux: influence of lifestyle diet and psycholgical factors. Abstracts of the Digestive Disease Week 2002; S1356: A-268.
12. Gray MR, Donnelly RJ & Kingsnorth AN. Role of salivary epidermal growth factor in the pathogenisis of Barrett's columnar lined oesophagus. Br J Surg 1991; 78:1461-6.
13. Orsini B, Brocchi A, Calabrà A, Fedip, Tommasi MS, Surrenti C. Radioimmunoassay of Epidermal Growth Factor in Human Saliva and Gastric Juice. Clin Biochem 1991; 24:135-41.
14. Gill GA, Arthur C, Hampson F, Dettmar P, Moorghen M, Pigna Telli M. Characterization of acid and pepsin damaged laryngeal and oesophageal mucosa. Abstracts of the Digestive Disease Week 2002; TII 15: A-595.
15. Mcgurck M, Hanford L, Justice S, Metcalfe RA. The Secretory Characteristics of Epidermal Growth Factor in Human Saliva. J Oral Biol 1990; 35(8): 653-9.
16. Sarosiek J, Scheurich CJ, Marcinkiewicz M, Mccallum RW. Enhancement of Salivary Esophagoprotection: Rationale for a Physiological Approach to Gastroesophageal Reflux Disease. Am J Gastroenterol 1996; 110:675-81.
17. Chicharro JL, Lucia A, Perez M, Vaquero AF, Urena R. Saliva composition and exercise. Sports Med 1998 Jul; 26(1): 17-27.
18. Chen SD, Kao CH, Chang CS, Chen GH. Salivary function in patients with reflux esophagitis: effect of cisapride. J Nucl Med 1998 Aug; 39(8): 1449-52.
19. Beal AM. The effect of transport-blocking drugs on secretion of fluid and electrolytes by the mandibular gland of red kangaroos Macropus rufus. Arch Oral Biol 1997 Oct-Nov; 42(10-11): 705-16.
20. Costa HO, Eckley CA, Fernandes AMF, Destailleur D, Villela PH. Refluxo gastroesofágico: comparação entre os achados laríngeos e digestivos. Rev Port ORL 1997; 35(1): 21-6.
21. Eckley CA & Costa HO. Manifestações otorrinolaringológicas da doença do refluxo gastroesofágico In: Martinez JC. Atheneu Affecções Cirúrgicas do Estômago e Intestino Delgado. São Paulo; 2002 (no prelo)
22. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101(Suppl): 1-78.
23. Sarosiek J & Mccallum RW. What Role do Salivary Inorganic Components Play in Health and Disease of the Esophageal Mucosa? Digestion 1995, 56 (Suppl 1): 24-31.
24. Sarosiek J & Mccallum RW. Do Salivary Organic Components Play a Protective Role in Health and Disease of the Esophageal Mucosa? Digestion 1995; 56(Suppl 1): 32-7
25. Shaw GY & Searl JP. Laryngeal Manifestations of Gastroesophageal Reflux before and after Treatment with Omeprazole. S Med J 1997; 90(11): 1115-22.
26. Cianci R, Fedeli G, Cammarota G, Galli J, Agostino S, Di Girolamo S, Maurig M, Gasbarrini G. Is the alkaline reflux a risk factor for laryngeal lesions? Am J Gastroenterol 2000; 95(9):2398 (carta).